Emergent BioSolutions Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
EBS New York 2836 www.emergentbiosolutions.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Emergent BioSolutions Inc.

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans - Feb 7th, 2025 1:06 pm
Emergent seeking to reverse fortunes and become a major overdose treatment player - Jan 23rd, 2025 2:01 pm
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA) - Jan 16th, 2025 1:00 pm
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals - Jan 14th, 2025 12:30 pm
Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola - Jan 13th, 2025 2:27 pm
Those who invested in Emergent BioSolutions (NYSE:EBS) a year ago are up 365% - Jan 9th, 2025 12:21 pm
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 - Jan 8th, 2025 12:45 pm
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed) - Jan 8th, 2025 12:30 pm
Why Emergent BioSolutions Stock Blasted Higher Today - Dec 30th, 2024 10:26 pm
Emergent Stock Skyrockets 251% YTD: How to Play the Stock? - Dec 27th, 2024 1:34 pm
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) - Dec 16th, 2024 1:00 pm
Why Emergent BioSciences Stock Plummeted Today - Dec 3rd, 2024 11:47 pm
Emergent BioSolutions Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Nov 9th, 2024 1:18 pm
Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Nov 8th, 2024 3:04 pm
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024 - Nov 7th, 2024 7:06 pm
New Strong Buy Stocks for November 7th - Nov 7th, 2024 10:30 am
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript - Nov 7th, 2024 6:15 am
Emergent Biosolutions (EBS) Q3 Earnings Beat Estimates - Nov 6th, 2024 11:20 pm
Emergent Biosolutions: Q3 Earnings Snapshot - Nov 6th, 2024 10:17 pm
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa - Nov 6th, 2024 9:49 pm